Martina Baiardo Redaelli

Martina Baiardo Redaelli

Auto-generated profile, based on publicly available information

Martina Baiardo Redaelli

Department of Biotechnologies and Life Sciences University of Insubria Varese Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Anesthesiology
Verified
Journal Article
Closed access
MRMartina Baiardo Redaelli
Martina Baiardo Redaelli
FMFabrizio Monaco
Fabrizio Monaco
NBNikola Bradic
Nikola Bradic
ASAnna Mara Scandroglio
Anna Mara Scandroglio
LTLian Kah Ti
Lian Kah Ti
FCfor the PROTECTION Study Group Collaborators
for the PROTECTION Study Group Collaborators
Background: In the PROTECTION trial (Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery), intravenous amino acids decreased the occurrence of acute kidney injury in cardiac surgery patients with cardiopulmonary bypass. Recruitment of renal functional reserve may be responsible for such protection. However, patients with chronic kidney disease have diminished renal functional reserve, and amino acids may be less protective in such patients. Thus, a separate investigation of such patients is warranted. Methods: For this study chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml · min−1 · 1.73 m−2, and patients with estimated glomerular filtration rates greater than or equal to 60 ml · min−1 · 1.73 m−2 served as controls. The primary outcome was the occurrence of acute kidney injury. Secondary outcomes included severity of acute kidney injury, need for and duration of renal replacement therapy, and all-cause mortality. Results: Among chronic kidney disease patients (n = 812), compared with placebo, amino acids significantly decreased the rate of acute kidney injury (43.1% vs 50.3%; relative risk, 0.86; 95% CI, 0.74 to 0.99; P = 0.041; number needed to treat = 14) with a median percentage increase in estimated glomerular filtration rate from baseline to postoperative day 3 of 12.7% versus 6.5% (P = 0.002). In estimated glomerular filtration rate–based chronic kidney disease subgroups (30 to 39, 40 to 49, and 50 to 59 ml · min−1 · 1.73 m−2), the amino acid effect was similar (interaction P = 0.50). Finally, amino acid infusion decreased the occurrence of severe (stage 3) acute kidney injury (2.7% vs. 5.6%; relative risk 0.48; 95% CI, 0.24 to 0.98; P = 0.038). Conclusions: Amino acid infusion protected chronic kidney disease patients undergoing cardiopulmonary bypass from developing acute kidney injury, with an absolute risk reduction of 7% and a number needed to treat of 14 in a cohort with a greater than 45% rate of acute kidney injury. Moreover, it delivered a greater than 50% relative risk reduction in severe acute kidney injury.

30 November 2022 in European Journal of Trauma and Emergency Surgery
Verified
Journal Article
Closed access
PDF file
OSOrnella Spagnolello
Ornella Spagnolello
SGSofia Gatti
Sofia Gatti
MSMir Abdul Azim Shahir
Mir Abdul Azim Shahir
MAMohammod Fahim Afzali
Mohammod Fahim Afzali
GPGina Portella
Gina Portella
MRMartina Baiardo Redaelli
Martina Baiardo Redaelli

24 February 2026 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
GLGiovanni Landoni
Giovanni Landoni
AOAlessandro Oriani
Alessandro Oriani
LTLian Kah Ti
Lian Kah Ti
Rosario LosiggioRosario Losiggio
Rosario Losiggio
NBNikola Bradic
Nikola Bradic
FMFabrizio Monaco
Fabrizio Monaco

17 September 2025 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
AGAlessandra Agnese Grossi
Alessandra Agnese Grossi
MRMartina Baiardo Redaelli
Martina Baiardo Redaelli
FPFrancesco Procaccio
Francesco Procaccio
MPMario Picozzi
Mario Picozzi
GCGiuseppe Citerio
Giuseppe Citerio
LCLuca Cabrini
Luca Cabrini
Purpose Donation after circulatory death (DCD) represents a valuable opportunity to expand the organ donor pool. However, its implementation in intensive care units (ICUs) remains ethically and emotionally complex. ICU healthcare professionals (HCPs) play a pivotal role in this process, yet their attitudes, knowledge, and perceived challenges are not fully understood. This systematic review aimed to explore ICU HCPs’ attitudes (as defined by Rosenberg and Hovland) toward controlled DCD (cDCD). Methods We conducted a systematic review of studies published until March 2025 in four databases. Eligible studies included original research reporting ICU-specific data on HCPs’ attitudes toward DCD. Study quality was assessed using the Mixed Methods Appraisal Tool. A structured narrative synthesis was performed. Results Twenty-five studies involving 3,878 HCPs were included. Overall, support for DCD was evident though it remained lower than for donation after brain death. Ethical concerns focused on potential conflicts of interest between the withdrawal of life-sustaining treatment and the pursuit of organ donation, the timing of withdrawal, the urgency of organ retrieval, and the challenge of balancing compassionate end-of-life care with procedural imperatives. Common barriers included the lack of standardized protocols, insufficient training, and uncertainty surrounding death determination. Conclusions While ICU HCPs generally support DCD, significant ethical tensions and systemic barriers persist. Institutional efforts should focus on implementing clear protocols, promoting interprofessional education, and providing emotional support to ensure ethical integrity and staff well-being. Future research should explore differences in attitudes between uDCD and cDCD and work toward the development of validated tools to assess professional attitudes.

21 November 2025 in Journal of Anesthesia, Analgesia and Critical Care
Verified
Journal Article
Open access
PDF file
FMFederica De Min
Federica De Min
MDMaria Assunta Donato
Maria Assunta Donato
ERElisa Raimondo
Elisa Raimondo
AMAlessandro Ivan De Martino
Alessandro Ivan De Martino
ABAlessia Bresil
Alessia Bresil
LCLuca Cabrini
Luca Cabrini
Background: A wide gap exists between the number of patients awaiting organ transplantation and the availability of donor organs. For most vital organs, no artificial substitutes are available, resulting in the death of approximately 3–4% of patients on transplant waiting lists. Deceased organ donation occurs through one of two pathways: donation after brain death (DBD) or after controlled circulatory death (cDCD). In the absence of documented consent during the patient’s lifetime, many countries rely on family members to make the decision, placing an emotional burden on them during a time of acute grief. Data on family attitudes toward organ donation, particularly in relation to the mode of death (DBD vs. cDCD), remains limited. This study aimed to examine the frequency of family refusal in the context of deceased organ donation and assess whether it differs between DBD and cDCD cases. Methods: This retrospective, single-center observational study analyzed 6 years of hospital data (2019–2024) from five intensive care units at a tertiary university hospital in Varese, Italy. All patients, regardless of age, who were eligible for deceased organ donation through either DBD or cDCD were included. Results: A total of 158 patients were evaluated for donation (135 DBD; 23 cDCD). Documented opt-in consent, as recorded in the national donor registry, was available for 41 patients (20%), while 3 had registered their refusal. Two patients were ineligible for donation; for the remaining 112 patients (71%), consent was sought from family members. Family refusal occurred in 28 cases (25% of the 112 families asked for consent). No significant difference in consent rates was observed between DBD and cDCD pathways (DBD: 73/98 vs. cDCD: 11/14; p = 0.74). Conclusions: Family refusal was the leading reason for missed donation opportunities among patients without documented opt-in consent, accounting for one in four cases. The donation pathway (DBD vs. cDCD) did not significantly influence family decision-making. Given ongoing organ shortages and high wait-list mortality, strategies are needed to support family decisions and to promote the formal registration of opt-in consent among citizens.

19 February 2025 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
OSOrnella Spagnolello
Ornella Spagnolello
SFSilvia Fabris
Silvia Fabris
SEShekiba Esmati
Shekiba Esmati
ADArezo Dost
Arezo Dost
MAMuhebullah Ahmadzai
Muhebullah Ahmadzai
MRMartina Baiardo Redaelli
Martina Baiardo Redaelli
Background Traumatic brain injuries (TBIs) are a common cause of morbidity and mortality in war zones. Currently, the vast majority of reports on war-related TBIs concern soldiers, and little is known about this condition in civilians. Methods This is a retrospective observational study from the EMERGENCY NGO hospital for civilian war victims in Kabul, Afghanistan. Data were gathered for all adults and children with war-related TBIs admitted between June and November 2021. The study aims to describe the epidemiology and clinical patterns of patients with war-related TBIs in a non-military context. Results Out of a total of 1469 hospital admissions during the study period, 130 (8.8%) were war-related TBIs. Among these, 90 (69.2%) involved a penetrating brain injury. More than one-third of the study population were children aged 14 or younger (36.1%), and the most frequent cause of war-related TBIs was shells (58.1%). The median time from injury to admission was 3 hours (from 30 min to 3 days), with only 19% of patients presenting in the ‘golden hour’. Neurosurgery was performed on 38 patients (29.2%), and 55 patients (42.3%) underwent mechanical ventilation. In-hospital mortality occurred in 35 patients (26.9%), including 15 do-not-resuscitate cases. Conclusions War-related TBIs were frequent among adults and children and had a high mortality rate. With more than one-third of patients undergoing mechanical ventilation, our data highlight that the availability of intensive care units with the ability to ventilate patients is of the utmost importance to save lives of civilians in areas of armed conflict.